𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effectiveness of health-related quality-of-life measurement in clinical practice: a prospective, randomized controlled trial in patients with chronic liver disease and their physicians

✍ Scribed by Jolie J. Gutteling; Anne-Sophie E. Darlington; Harry L. A. Janssen; Hugo J. Duivenvoorden; Jan J. V. Busschbach; Robert A. de Man


Publisher
Springer Netherlands
Year
2008
Tongue
English
Weight
307 KB
Volume
17
Category
Article
ISSN
0962-9343

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Efficacy and safety of high-dose pravast
✍ James H. Lewis; Mary Ellen Mortensen; Steven Zweig; Mary Jean Fusco; Jeffrey R. πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 148 KB πŸ‘ 2 views

The hepatotoxic potential of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in patients with underlying chronic liver disease remains controversial. We performed a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial that compared pravastatin (80 mg) to a place